| Particulars (Rupees in Crores.) | Sept-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 |
|---|---|---|---|---|---|
Gross Sales | 225.26 | 133.58 | 161.77 | 148.39 | 160.71 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 225.26 | 133.58 | 161.77 | 148.39 | 160.71 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.3 | 0.87 | 0.73 | 0.98 | 0.59 |
Total Income | 226.57 | 134.46 | 162.5 | 149.37 | 161.3 |
Total Expenditure | 166.08 | 92.65 | 125.78 | 110.44 | 127.81 |
PBIDT | 60.49 | 41.81 | 36.72 | 38.93 | 33.49 |
Interest | 12.6 | 12.03 | 10.58 | 8.76 | 7.28 |
PBDT | 47.9 | 29.78 | 26.14 | 30.18 | 26.21 |
Depreciation | 4.75 | 4.49 | 4.14 | 3.99 | 3.75 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 9.36 | 4.86 | 6.24 | 5.77 | 4.89 |
Deferred Tax | 3.77 | 2.74 | 1.79 | 2.18 | 1.85 |
Reported Profit After Tax | 30.03 | 17.68 | 13.96 | 18.24 | 15.73 |
Minority Interest After NP | -1.08 | -0.83 | -0.04 | -0.02 | 0.03 |
Net Profit after Minority Interest | 31.11 | 18.51 | 14 | 18.26 | 15.7 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 31.11 | 18.51 | 14 | 18.26 | 15.7 |
EPS (Unit Curr.) | 0.93 | 0.56 | 0.46 | 0.6 | 0.52 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 33.56 | 33.35 | 30.65 | 30.65 | 30.65 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 26.85 | 31.29 | 22.69 | 26.23 | 20.83 |
PBDTM(%) | 21.26 | 22.29 | 16.15 | 20.33 | 16.3 |
PATM(%) | 13.33 | 13.23 | 8.62 | 12.29 | 9.78 |
The board approved the issuing of 2.45 Crore convertible equity warrants on a preferential basis to promoters and non-promoter businesses.
Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.